| Literature DB >> 26682056 |
Anusree Mahanta1, Shashi Baruah1.
Abstract
Interleukin (IL)-10, a non-redundant anti-inflammatory cytokine is produced by different cells and its production involves activation of cell-specific transcriptional regulatory machinery in response to specific pathogen. We have previously demonstrated downregulated levels of IL-10 in severe falciparum malaria. The present study investigated transcriptional regulation of IL-10 in severe malaria. Comparative expression analysis of cell-specific signalling proteins and transcription factors for IL-10 production during the stage of active infection and with resolution of parasitaemia was performed. Interestingly, T-bet and GATA3, the Th1 and Th2 transcription factors, respectively, were downregulated in severe malaria with fold change values of 0.59 and 0.86. Increase in the levels of both the factors with resolution of parasitaemia implicated a role for parasite in depressed levels of these factors. Further support for probable parasite manipulation of GATA3 was obtained from negative correlation of GATA3 with parasitaemia. In addition, a role for interferon-α in suppressing IL-10 transcription was evident from its negative correlation with GATA3 and IL-10 levels. In summary, IL-10 transcription in Th1 and Th2 is defective and appears to have major contribution to low levels in severe malaria.Entities:
Year: 2015 PMID: 26682056 PMCID: PMC4673438 DOI: 10.1038/cti.2015.30
Source DB: PubMed Journal: Clin Transl Immunology ISSN: 2050-0068
Clinical data and relative mRNA expression of IL-10, IL-1β and TNF-α of two SM samples that showed different expression profile of the IL-10 transcriptional regulatory factors than the other patients
| Nausea | Yes | Yes |
| Vomiting | Yes | Yes |
| Jaundice | Yes | No |
| Temperature (Fahrenheit) | 101 | 99 |
| Hb (g dl−1) | 7 | 7.4 |
| Red colour of urine | Yes | No |
| Pulse per min | 90 | 90 |
| Respiration per min | 18 | 16 |
| BP (mm Hg) | 120/70 | 110/70 |
| Glasgow coma scale | 8 | 15 |
| Blood urea (mg dl−1) | 60 | 36 |
| Serum creatinine (mg dl−1) | 2.3 | 1.1 |
| Serum sodium (mmol l−1) | 135 | 130.1 |
| Serum potassium (mmol l−1) | 3.2 | 3.22 |
| Fold change of IL-10 | 0.000179 | 1.002209 |
| Fold change of IL-1β | 0.000163 | 1.740216 |
| Fold change of TNF-α | 2.234853 | 3.224446 |
Abbreviations: BP, blood pressure; Hb, haemoglobin; IL, interleukin; SM, severe malaria; TNF, tumour necrosis factor.
The relative expression of the three cytokines was determined previously by TaqMan assay.[6] Expression analysis have also been performed using SYBR Green assay in the present study (Supplementary figure 3).
Figure 1k-means clustering analysis to group genes based on similar temporal expression profile from day 0 (stage of active infection before treatment) till day 3 (stage of parasite clearance post artesunate treatment) in (a) SM. The relative fold change was calculated with 2−ΔΔCt formula using UM as the calibrator. 1, 2 and 3 denote the three clusters generated. The components of each of the clusters in SM are given in b.
Figure 2k-means clustering analysis in (a) SM and (b) UM. The relative fold change was calculated with 2−ΔΔCt formula using healthy control as the calibrator. 1, 2 and 3 denote the three clusters generated in the two disease groups. The components of each of the clusters in SM and UM are given in c.
Figure 3mRNA expression profile of regulatory factors and cytokines, which were found to cluster differently in SM by k-means clustering analysis. Statistical comparison of day 0 expression levels between SM and UM was performed by unpaired t-test while expression levels between day 0 and day 3 within the disease groups was done by Student's paired t-test. Data are represented as ±s.e.m. *P<0.05 and **P<0.0001.
Figure 4Correlation between cytokines, regulatory factors and parasitaemia in (a–e) SM and (f) UM. ((a) r=−0.730, 0.732, P=0.01, 0.01; (b) r=−0.859, 0.705, P=0.001, 0.02; (c) r=0.407, P=0.24; (d) r=0.427, 0.532, P=0.21, 0.11; (e) r=0.124, −0.665, P=0.73, 0.03; (f) r=0.459, 0.759, P=0.18, 0.01).
Figure 5mRNA expression profile of SOCS3. *P<0.05. Data are represented as ±s.e.m.
Sequences of designed primers for SYBR Green gene expression analysis
| TCGCCCTTTGCTTTACTGATG | |
| CAGAGAGCAGCTTGACTTGCA | |
| TGCCTCAAGGACAGGATGAAC | |
| GGAACTGCTGCAGCTGCTTA | |
| CCCTGATCGGTGGCTTCTTA | |
| GATGCCAAGACTCCAGTCCTAAA | |
| TGCCGCTCCCAACTTACAG | |
| TGTGGGATTACTTGATACTGAATATTAGG | |
| GGGTCTGAGACTCCCTTTCCTT | |
| CTCATTGGTCCCCCAGGAT | |
| GATGCGCCAGGAAGTTTCA | |
| GTTGGACGCCCCCTTGTT | |
| GATGCGCTGAGTGAGAACAAGA | |
| TTGAGGGTTTCCAAGGACTTCA | |
| AGGCAAGGACCTAGCAACACTTA | |
| GCTGGTGATAATTGGACTGGAAAC | |
| GTGATGCCCCAAGCTGAGA | |
| CCCCCAGGGAGTTCACATG | |
| TCAGCCAATCTTCATTGCTCAA | |
| TGGCGAGCTCAGGTACTTCTG | |
| CCTGCCCCAATCCCTTTATT | |
| GCCCCCAATTCTCTTTTTGAG |